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Objective: To compare gestational age (GA) estimates in early pregnancy, determined by last menstrual period
(LMP), human chorionic gonadotropin (hCG) concentration, ultrasound crown–rump length (Hadlock formula),
and ovulation day (luteinizing hormone surge plus 1 day).Methods: Female volunteers seeking to conceive (at 5
US sites) collected daily early-morning urine for up to 3 menstrual cycles. Pregnant women underwent ultra-
sound dating scans. Conception cycle urine was quantitatively assessed for luteinizing hormone and hCG. Sum-
mary statistics for GA using each referencemethodwere determined (n = 131). Results: Correlation betweenGA
determined by ultrasound and ovulation day was excellent (maximum difference 10 days); however, pregnan-
cies dated by ultrasound were 3 days advanced. The difference between LMP estimates and estimates based on
ovulation day or ultrasoundwas 9 and 12 days, respectively. A uniform rise in hCG on each day of pregnancywas
seen using all reference methods. The accuracy of hCG measurement in determining the week since conception
wasmore than 93%. Conclusion:Methods for establishing pregnancy duration vary in their accuracy and their GA
estimates. The rise in hCG concentration in early pregnancy is uniform and therefore hCG levels provide themost
accurate, early estimation of GA in single, viable pregnancies.
ClinicalTrials.gov: NCT01077583
© 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Accurate establishment of the pregnancy duration is essential for
optimum pregnancy care. It is used to assess pregnancy normality and
mother/fetus well-being, and to potentially guide delivery timing.
Historically, pregnancy is dated using the ﬁrst day of the last men-
strual period (LMP). However, the LMPmethod is frequently inaccurate.
It assumes a 28-daymenstrual cycle and ovulation on Day 14; however,
follicular phase duration varies between women, and ovulation leading
to conception can occur from cycle Day 9 to Day 30 [1]. Furthermore,
many women have poor LMP recollection. In one study [2], only 32%
of women were certain of their LMP date and number preference was
observed; the 1st, 5th, 10th, 15th, and 20th of the month were most
frequently stated, indicating a degree of guesswork by many women.
Other confounding factors are early pregnancy bleeding, recent
hormonal contraception use, and recent breastfeeding. Despite these
shortfalls, the date of the LMP is usually the only piece of data available
in very early pregnancy to determine gestational age (GA); therefore, ity, Priory Business Park, Bedford
35 006.
son).
ration of Gynecology and Obstetrics. Premains the most commonly used method for estimating GA and
assigning a due date (EDC).
In later pregnancy, ﬁrst-trimester ultrasound is used to estimate
GA. In the UK, the standard-of-care ultrasound between 11 + 0 and
13 + 6 weeks after the LMP estimates GA based on crown–rump
length (CRL) converted to GA using the validated Robinson formula [3],
which gives an estimate with an error range of 5 days [4–6] (other for-
mulae provide slightly different estimates [7,8]). The inclusion of CRL
measurement in the ﬁrst-trimester aneuploidy screen is also recom-
mended by the American College of Obstetrics and Gynecology [9],
with the Hadlock formula [7] being used most often to convert the
CRL to GA.
A more accurate measure of GA is the day of fertilization (if known
or determined). Human eggs have a lifespan of less than 1 day and
ovulation usually occurs 24–36 hours following the luteinizing hor-
mone (LH) surge [10]. Thus, the date of the LH surge can be used to
calculate the fertilization day (LH surge plus 1 day), and an idealized
follicular phase of 14 days can be added to align this value to LMP-
derived GA. Unfortunately, such information is not usually available
in natural conceptions.
Human chorionic gonadotropin (hCG) is a hormoneproduced by the
embryo in the very earliest stages of pregnancy. It is amarker of implan-
tation and its use is established in pregnancy testing [11,12] by profes-
sionals and in home urine pregnancy tests, many of which achieveublished by Elsevier Ireland Ltd. All rights reserved.
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rise exponentially and predictably during early pregnancy and relate to
pregnancy duration [14].
To date, no direct comparison of different methods for estimating
GA in spontaneous pregnancies has been undertaken in a single study.
The present study was designed to directly compare GA estimates
based on ovulation day (LH surge date plus 1 day), ultrasound CRL
(using the Hadlock formula [7]), hCG concentration, and accurately
obtained LMP. In addition, it aimed to establish whether urine hCG
concentration measurement enables an accurate estimation of GA,
compared with ultrasound and ovulation-based dating. The availability
of an accurate method at presentation would facilitate the timing of
early pregnancy care.
2. Materials and methods
The present study was a multicenter prospective study conducted
from January 28, 2010, to July 21, 2011, and approved by the Quorum
Review Institutional Review Board. Volunteers were recruited via
radio/newspaper advertising from the general population at 5 geograph-
ically distinct sites in the USA (Chicago, IL; Atlanta, GA; Minneapolis,
MN; San Antonio, TX; and Dallas, TX). Women were eligible if they
were 18–45 years of age, hadmenstrual bleeds, were trying to conceive,
and intended to seek pregnancy medical care. Exclusion criteria in-
cluded previous infertility treatment, participation in an assisted fertil-
ity program, and any medical condition contraindicating pregnancy.
Suitable volunteers attended a screening visit; they were given study
information and asked to provide written informed consent and their
medical history.
The volunteers were provided with the following trial material
in sufﬁcient quantities for 3 menstrual cycles: home ovulation tests
(Clearblue Digital Ovulation Test; SPD Swiss Precision Diagnostics,
Geneva, Switzerland) to aid conception, urine collection containers
(containing the preservative sodium azide), a daily diary, and home
pregnancy tests (Clearblue Pregnancy Test; SPD Swiss Precision Diag-
nostics). At their next menstrual cycle, the volunteers started collecting
early-morning urine samples and used the ovulation tests to detect the
LH surge. The volunteers performed a home pregnancy test on their
approximate expected period (EP) day; the test was repeated 2–3 days
later if menses did not occur. Sample collection was continued for a
maximum of 3 menstrual cycles.
Volunteers obtaining a positive pregnancy test were instructed to
inform their trial center and continue collecting daily urine samples
for a further 4 weeks from the EP date. A transabdominal/transvaginal
ultrasound dating scanwas performed on pregnant volunteers between
11 + 0 and 13 + 6 weeks following the date of their LMP, using ultra-
soundmachines cleared by theUS Food andDrugAgency, in accordance
with the Fetal Medicine Foundation methodology (Supplementary
Material S1). The digital scan images were sent to an independent
expert for central review and conﬁrmation of the CRL; scans of unac-
ceptable quality were repeated.
Quantitative LH and hCG testing was conducted using a validated
quantitative automated immunoassay system (AutoDELFIA; PerkinElmer,
Waltham, MA, USA) [15] (see Supplementary Material S2 for the meth-
odology). Urine samples from the start of collection until the date of the
EP minus 6 days were used to determine the LH surge day. The date of
the EP was deﬁned as the LH surge date plus 15 days. Urine samples
from 6 days prior to the EP date until the last day of sample collection
were tested for hCG. The daily diaries were used to recordmenses, sam-
ple collection, and home test results (the informationwas transferred to
the study database using the TeleForm [Cardiff-Teleform, UK] automat-
ed data entry system).
On the day samples were provided to the study center, the GA was
determined using the 3 reference methods; the results were aligned
based on the day of the EP. For the LMP method, the EP day was calcu-
lated as date of the LMP plus normal cycle length; for the ovulation daymethod, it was calculated as LH surge day plus 15 days; for ultrasound
dating, the EP day was calculated by converting the CRL to GA using
the Hadlock formula [7] with extrapolation back to the sample date,
minus 14 days. The median and the 10th and 90th centiles of the uri-
nary hCG level were calculated for each day of pregnancy as estimated
using the 3 pregnancy dating methods.
To investigate the usefulness of hCG measurement for pregnancy
dating, the median hCG concentrations at 14 days or less, 15–21 days,
and 22 days or more since ovulation were calculated. Beyond
3 weeks, the hCG trajectory begins to plateau; therefore, the assign-
ment of further time intervals based on hCG concentrations would be
inaccurate. Using these time intervals, a modeling exercise was
conducted to determine whether assessment of GA based on the
hCG concentration was correct, compared with GA based on the
ovulation day.
The sample sizewas based on the requirement to obtain data on 100
single viable pregnancies to provide a reasonable evaluation of hCG pro-
ﬁles compared with reference standards. The statistical analysis was
performed using SAS version 9.2 (SAS Institute, Cary, NC, USA). The
methods for determining GA were compared using paired t tests, and
themean difference and 95% conﬁdence intervals (CIs)were calculated;
2methodswere considered signiﬁcantly different if the CIs did not con-
tain zero. In addition, the median and interquartile range (IQR) of the
hCG concentration were calculated for each race/ethnicity and com-
pared graphically; a formal comparison was not possible because of
the low sample size on certain days.
3. Results
The study recruited 1640 eligible volunteers over 10 months, 135 of
whom became pregnant before the start of their next cycle, so were not
able to participate in the study. Of the participating volunteers (n =
1505), 250 became pregnant and 178 womenwith a single viable preg-
nancy completed the study; of the remaining women who became
pregnant, 42 had a spontaneous abortion, 1 had a multiple pregnancy,
2 had an ectopic pregnancy, and 27 were lost to follow-up/withdrew
consent. The overall pregnancy rate in the study was 23.5% (385/1640
women); the rate among those leaving the study early (n = 650) is
unknown. The conﬁrmed pregnancy rate for women completing the
study (n = 990) was 38.9% (385/990 women); 117, 79, and 54 preg-
nancies were conceived during cycle 1, 2, and 3, respectively. Samples
were available for analysis from 153 pregnancies (including 3 volun-
teers who left the study early). Samples from 131 volunteers were
available for inclusion in all analyses (data on the laboratory-
determined LH surge date and the CRL were not available for 7 and 15
volunteers, respectively).
The study population demographics are provided in Table 1. The
study population was similar in age to the US conceiver population
[16–18]; however, their educational status was higher, and the propor-
tion of black women was lower among the volunteers with samples
available for analysis.
There was excellent correlation between the GA determined by
ultrasound and that based on ovulation day. An approximately nor-
mal distribution was observed when the discrepancy between the
GA estimates provided by the 2 methods was examined (Fig. 1a);
the plot centered on the EP day of most agreement, with a discrepan-
cy range of 6 days. Overall, the GA estimated by ultrasound was
higher by an average of 3 days (mean difference, 3.1 days; 95% CI
2.7–3.5 days). The relationship between the ovulation day and ultra-
sound methods versus the LMP method was more variable. For LMP
versus ultrasound, it reached up to 13 days (mean difference 2.5;
95% CI 1.8–3.2) (Fig. 1b); for LMP versus ovulation day, the discre-
pancy was up to 14 days (mean difference 0.7; 95% CI 0.1–1.2)
(Fig. 1c).
There was a consistent rise in the daily hCG concentration with ad-











Mean ± SD 30.6 ± 5.4 30.8 ± 4.1 30.4 ± 4.0
Median (range) 30.0 (18.0–45.0) 31.0 (20.0–42.00) 30.0 (20.0–40.0)
Educational status
High school 250 (16.6) 10 (4.0) 5 (3.3)
College/graduate school 1099 (73.0) 201 (80.4) 130 (85.0)
Post graduate school 155 (10.3) 39 (15.6) 18 (11.8)
No information 1 (0.1) 0 (0.0) 0 (0.0)
Ethnicity
White 958 (63.7) 202 (80.8) 131 (85.6)
Hispanic or Latino 276 (18.3) 25 (10.0) 12 (7.8)
Asian 59 (3.9) 14 (5.6) 7 (4.6)
Black or African American 442 (29.4) 26 (10.4) 10 (6.5)
Native Hawaiian/other Paciﬁc Islander 5 (0.3) 0 (0) 0 (0.0)
American Indian or Alaska Native 19 (1.3) 4 (1.6) 2 (1.3)
Mixed 22 (1.5) 4 (1.6) 3 (2.0)
Menstrual cycle history, d
Mean ± SD 29.5 ± 5.8 29.6 ± 4.5 29.6 ± 2.9
Range 8–183 19–85 22–39
Previous pregnancies
0 682 (45.3) 95 (38.0) 60 (39.2)
1 384 (25.5) 81 (32.4) 55 (35.9)
2 241 (16.0) 47 (18.8) 27 (17.6)
≥3 198 (13.1) 27 (10.8) 11 (7.2)
a Values are given as number (percentage) unless otherwise indicated.
191J. Larsen et al. / International Journal of Gynecology and Obstetrics 123 (2013) 189–195of the 10th to 90th centile range varied; the least variability was ob-
served for GA dating based on ovulation day, and the highest variability
was observed using LMP. The median daily hCG concentrations were
very similar if GA was estimated using the ovulation day and LMP
methods. However, when GA was based on ultrasound dating, the me-
dian hCG concentration was lower on each day, in agreement with the
observation that GA calculated by ultrasound was on average 3 days
advanced, compared with GA based on ovulation day.
No hCG proﬁle differenceswere observed betweenwomen fromdif-
ferent ethnic groups. The daily hCG median values and the 10th and
90th centiles for Hispanic and non-Hispanic volunteers were compara-
ble (Fig. 3a), as were the values for white, black, and Asian volunteers
(Fig. 3b). For example, on Day 23 post-ovulation, the median hCG
concentration was 3185 mIU/mL (IQR, 1836–4964 mIU/mL) and 3449
mIU/mL (IQR, 2329–6259 mIU/mL) for Hispanic and non-Hispanic
volunteers, respectively, and 3422 mIU/mL (IQR 2329–6068 mIU/mL),
3355 mIU/mL (IQR2891–6371 mIU/mL), and 3921 mIU/mL (IQR,
3474–6729 mIU/mL) for white, black, and Asian volunteers. The ob-
served exponential rise in hCG concentration in all pregnant volunteers
overrode any race or ethnic variability.
The day of ﬁrst hCG appearance can be considered as an implanta-
tion marker, and this date also varied between the 3 comparator
methods (Fig. 4); hCG was ﬁrst detected on Day −6 with respect
to EP when using the ovulation day and ultrasound methods, and on
Day −12 using LMP. The range of estimated implantation days was
smallest with the ovulation day method (6 days before EP to 2 days
thereafter) and greatest with the LMP method (12 days before EP to
6 days thereafter).
The agreement between the GA based on the hCG concentration and
the GA based on the ovulation day was 95.9% for a GA of 1–2 weeks,
93.4% for 2–3 weeks, and 95.2% for 3 or more weeks, illustrating the
ability of urinary hCG to provide an accurate early estimate of preg-
nancy duration.
4. Discussion
The present study shows that methods for establishing pregnancy
duration vary in their estimate of GA and in their accuracy. It alsoillustrates that urinary hCG is directly related to early GA, in agreement
with previous reports [1,19–21]. The rise in hCG level observed for each
day of pregnancy was uniform across the methods and the hCG levels
were substantially different for pregnancy durations of 14 days or less,
15–21 days, and 22 days or more; therefore, the urine hCG level pro-
vides an accurate and reliable indicator of GA. No difference in the
daily rise in urinary hCG concentration was seen between volunteers of
different ethnicities/races when the data were aligned using ovulation-
based pregnancy dating.
Traditionally, LMP is used to estimate GA but it is inherently
unreliable because of the variability in cycle length and women’s
poor recollection [2], as illustrated by the high degree of LMP vari-
ability in the present study. Ultrasound CRL measurement has be-
come the standard reference method for GA determination in many
countries. Limitations of ultrasound include the need for specialist
equipment with trained operators and the fact that it is performed
weeks after presentation. The present study reveals a systematic
bias in the algorithm used to convert CRL to GA, resulting in pregnan-
cy being on average 3 days more progressed if dated by ultrasound
as opposed to ovulation day. This is consistent with the bias reported
by Pexsters et al. [22], who found that the Hadlock formula system-
atically overestimated GA by 2 days. A recent study [23] comparing
pregnancy dating based on the day of oocyte retrieval in in-vitro
fertilization pregnancies with that based on CRL measurement in
later pregnancy generated a new conversion formula that equals GA
with the pregnancy duration determined using the Hadlock formula
minus 2 days. Although the discussed bias may have few clinical impli-
cations, it is an important factor to consider when using CRL as a refer-
ence method for GA in clinical studies.
The detection of hCG in urine is regularly used to conﬁrm pregnancy
in home pregnancy tests, but it is not currently used to estimate GA;
likewise, the day of ovulation/timing of the LH surge is not routinely
used for this purpose, because women usually present post-conception
when such data are unavailable. However, the data presented here
show that the hCG concentration can be used to provide an accurate
assessment of GA. Urine testing is easy and convenient for women and
hCG measurement is inexpensive; therefore, urinary hCG measure-
ment may be a cost-effective method to obtain a more accurate, early
Fig. 1. Plot of difference in gestational age estimated by (a) ultrasound versus ovulation
day, (b) ultrasound versus last menstrual period, and (c) last menstrual period versus
ovulation day.
Table 2
Levels of hCG in relation to duration of pregnancy estimated by ovulation day (LH surge),
LMP, and ultrasound (CRL measurement).
Gestational age,
wk (from EP)
Median hCG concentration (10th, 90th centile), mIU/mL
Ovulation day LMP Ultrasound
−2 38 (12, 97) 42 (1, 356) 6 (0.4, 30)
0 123 (44, 324) 145 (5, 805) 20 (3, 85)
2 328 (120, 781) 268 (11, 1682) 55 (8, 201)
4 820 (277, 1711) 660 (47, 3559) 167 (44, 637)
6 1511 (567, 5673) 1450 (119, 5769) 490 (105, 1243)
10 6397 (2227, 16585) 5820 (1092, 20218) 3122 (1051, 8082)
Abbreviations: CRL, crown–rump length; EP, estimated period; hCG, human chorionic
gonadotropin; LH, luteinizing hormone; LMP, last menstrual period.
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based on the day of ﬁrst hCG appearance, which has previously been
shown to serve as a surrogate for the day of implantation [10]; thepresent study indicates that the error range is small when using the
day of ﬁrst hCG appearance to determine the day of implantation in sin-
gle, viable pregnancies. The timing of implantation has previously been
shown to inﬂuence the fetus size determined by CRL measurement at
10–14 weeks [24].
The present study compared measurement of urine hCG concentra-
tions, ovulation dating (LH surge plus 1 day), LMP dating, and ultra-
sound CRL measurement as methods for determining GA. A high level
of agreement was observed between these methods. The correlation
of the GA estimates based on ovulation dating and hCG concentration
measurement was similar to that previously reported in a European
cohort [1] (the methodology and study population differed from that
reported here). The present study only considered single, viable preg-
nancies, and further studies are needed to examine the hCG concentra-
tion in women with a spontaneous abortion, ectopic pregnancy, or
pregnancy of unknown location. A limitation of the present study is
the lower than expected pregnancy rate (39% versus an expected rate
of 68% after 3 cycles [25]), which might be attributable to the inclusion
of women who had been trying to conceive for several years and were
potentially infertile. Home ovulation tests were provided to the volun-
teers to aid conception, which may have been an incentive for women
with fertility problems to volunteer. In addition, an extreme variation
in cycle length (range, 8–183 days), whichwas not an exclusion criteri-
on, was reported at admission, indicating potential subfertility in some
volunteers. Another possible limitation is that the educational status
of the study population was higher than average; 85% of the volunteers
analyzed had college/graduate school-level qualiﬁcations compared
with 29% of women aged over 25 in the 2008 US census [17]. Further-
more, despite an overrepresentation of black volunteers at study admis-
sion, the proportion of black womenwith samples available for analysis
was lower than that in the general population [18] because of a higher
rate of withdrawals/loss to follow-up in this group (62% versus 38%
for black and white volunteers, respectively).
In conclusion, the present study shows that hCG is the earliest accu-
ratemeasure of GA available. The hCG levels and their risewith increas-
ing pregnancy duration were consistent between ethnic groups and
therefore the urine hCG concentration can be used to accurately assess
GA. The urinary hCG level as a measure of GA was more reliable than
LMP and comparable with ultrasound CRL measurement. An advantage
of hCG measurement over ultrasound is that it can be used at an earlier
stage of pregnancy because it can give an accurate estimation of GA at
the time when menses would normally be due.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijgo.2013.05.028.Acknowledgments
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Fig. 2. Level of urine human chorionic gonadotropin versus pregnancy duration as determined by (a) ovulation day, (b) last menstrual period, and (c) ultrasound. Solid line represents the
median value and gray area the 10th and 90th centiles.
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